Document is current
Any future updates will be listed below
-
Authors
Matsumoto, Yoshinari
Shivappa, Nitin
Sugioka, Yuko
Tada, Masahiro
Okano, Tadashi
Mamoto, Kenji
Inui, Kentaro
Habu, Daiki
Hebert, James R.
Koike, Tatsuya http://orcid.org/0000-0002-1522-8740
- License Information
-
More Information
Article History
Received: 27 September 2020
Accepted: 12 March 2021
First Online: 8 April 2021
Declarations
:
: This study was conducted after written informed consent was obtained from all study subjects in accordance with the Declaration of Helsinki, and the research protocol was approved by Ethics Committee of the Osaka City University Hospital (approval number 1660).
: Consent for publication, using data from the TOMORROW study, has been obtained from all study subjects.
: YS, MT, KM, and DH declare no competing interests.YM: Grant/research support from Yamada Research Grant.NS is an employee of Connecting Health Innovations LLC (CHI).TO: Grant/research support from AbbVie, Eisai, Mitsubishi Tanabe Pharma Corporation, and Nipponkayaku; speakers bureau: AbbVie, Asahikasei, Astellas Pharma Inc., Ayumi Pharmaceutical, Bristol-Myers Squibb, Chugai Pharmaceutical, Daiich Sankyo, Eisai, Janssen, Lilly, Mitsubishi Tanabe Pharma Corporation, Novartis Pharma, Ono Pharmaceutical, Pfizer, Sanofi, Takeda Pharmaceutical, Teijin Pharma, and UCB.KI: Grant/research support from Janssen Pharmaceutical K.K., Astellas Pharma Inc., Sanofi K.K., Abbvie GK, Takeda Pharmaceutical Co. Ltd., QOL RD Co. Ltd., Mitsubishi Tanabe Pharma, Ono Pharmaceutical Co. Ltd., and Eisai Co., Ltd.; Speakers bureau: Daiichi Sankyo Co. Ltd., Mitsubishi Tanabe Pharma, Janssen Pharmaceutical K.K., Astellas Pharma Inc., Takeda Pharmaceutical Co. Ltd., Ono Pharmaceutical Co. Ltd., Abbvie GK, Pfizer Inc., Eisai Co., Ltd., and Chugai Pharmaceutical Co., Ltd.JRH owns controlling interest in Connecting Health Innovations LLC (CHI), a company that has licensed the right to his invention of the dietary inflammatory index (DII®) from the University of South Carolina in order to develop computer and smart phone applications for patient counseling and dietary intervention in clinical settings.TK: Grant/research support from AbbVie, Astellas Pharma Inc., Bristol-Myers Squibb, Chugai Pharmaceutical, Eisai, Janssen, Lilly, Mitsubishi Tanabe Pharma Corporation, MSD, Ono Pharmaceutical, Pfizer, Roche, Takeda Pharmaceutical, Teijin Pharma, and UCB; speakers bureau: AbbVie, Astellas Pharma Inc., Bristol-Myers Squibb, Chugai Pharmaceutical, Eisai, Janssen, Lilly, Mitsubishi Tanabe Pharma Corporation, MSD, Ono Pharmaceutical, Pfizer, Roche, Takeda Pharmaceutical, Teijin Pharma, and UCB.
